← 返回

微环境中增殖性 TIL(肿瘤浸润淋巴细胞)的丰度影响皮肤 B 细胞淋巴瘤的临床结局

英文原题:Proliferative Tumor-Infiltrating Lymphocytes' Abundance within the Microenvironment Impacts Clinical Outcome in Cutaneous B-Cell Lymphomas.

查看英文原题

Proliferative Tumor-Infiltrating Lymphocytes' Abundance within the Microenvironment Impacts Clinical Outcome in Cutaneous B-Cell Lymphomas.

PubMed 2022/08/13(内容时间) J Invest Dermatol Q1 · IF 7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

原发性皮肤大B细胞淋巴瘤,腿型(PCLBCL-LT)是最具侵袭性的原发性皮肤B细胞淋巴瘤(PCBCL)。肿瘤微环境在肿瘤发展中具有关键作用,TIL(肿瘤浸润淋巴细胞)(TILs)可作为免疫治疗的靶点。

我们对20例PCBCL中的TILs进行了特征分析,以识别与临床结局相关的肿瘤微环境特征。我们使用Opal染色开发了一个七重多重免疫荧光panel,并使用HALO软件进行图像分析。在PCLBCL-LT中,TILs稀疏地混杂在肿瘤浸润细胞中,而惰性PCBCL中TILs散在分布于肿瘤结节边缘,伴有不同程度的肿瘤浸润。在PCLBCL-LT中,TILs由CD8和CD4组成,而在惰性PCBCL中以CD4为主。增殖性TILs(CD3+Ki-67+细胞)在PCLBCL-LT中比在惰性PCBCL中更丰富(P = 0.0036)。在PCLBCL-LT中,增殖性TILs的丰度倾向于与更好的无进展生存期相关。这些数据在一个包含23例的第二个独立队列中得到证实,显示增殖性TILs在PCLBCL-LT中更丰富(P = 0.0205),并且在PCLBCL-LT中,高CD3+Ki-67+细胞密度与更好的无进展生存期相关(P = 0.002)。这些PCBCL之间TILs组成和分布的差异表明,增殖性T淋巴细胞代表PCLBCL-LT的一个良好预后因素,刺激其功能可能代表一种治疗途径。

展开英文摘要原文

Primary cutaneous large B-cell lymphoma, leg-type (PCLBCL-LT) is the most aggressive primary cutaneous B-cell lymphoma (PCBCL). Tumor microenvironment has a crucial role in tumor development, and tumor-infiltrating lymphocytes (TILs) can be targeted by immunotherapies.

We characterized TILs in 20 PCBCLs to identify the tumor microenvironment features associated with clinical outcomes.

We developed a seven‒multiplex immunofluorescence panel using Opal staining and image analysis using HALO software. In PCLBCL-LT, TILs were sparsely intermingled within tumor infiltrate in contrast to those in indolent PCBCL where TILs were scattered around tumor nodule edges with variable tumor infiltration. In PCLBCL-LT, TILs were composed of CD8 and CD4, whereas CD4 was predominant in indolent PCBCL. Proliferative TILs (CD3+Ki-67+ cells) were more abundant in PCLBCL-LT (P = 0. 0036) than in indolent PCBCL.

In PCLBCL-LT, proliferative TILs' abundance tended to be associated with better progression-free survival. These data were confirmed in a second independent cohort of 23 cases showing that proliferative TILs were more abundant in PCLBCL-LT (P = 0.

0205) and that in PCLBCL-LT, high CD3+Ki-67+ cell density was associated with better progression-free survival (P = 0. 002). These distinct TILs composition and distribution among PCBCL suggest that proliferative T lymphocytes represent a good prognostic factor in PCLBCL-LT and that stimulating their functions may represent a therapeutic approach.

论文信息

作者
Menguy S、Prochazkova-Carlotti M、Azzi-Martin L、Ferté T、Bresson-Bepoldin L、Rey C、Vergier B、Merlio JP
第一作者单位
INSERM U1312, Bordeaux Institute of Oncology, Translational Research on Oncodermatology and Rare Skin Diseases, Bordeaux University, Bordeaux, France; Pathology Department, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.France
通讯作者单位
INSERM U1312, Bordeaux Institute of Oncology, Translational Research on Oncodermatology and Rare Skin Diseases, Bordeaux University, Bordeaux, France; Dermatology Department, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France. Electronic address: anne.pham-ledard@chu-bordeaux.fr.France
文献类型
非美国政府资助研究
期刊
The Journal of investigative dermatology2023 Jan
原文标识
PubMed 35970476 · DOI 10.1016/j.jid.2022.06.027